Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Product Description for Axitinib (CAS: 319460-85-0)
Axitinib (CAS No. 319460-85-0) is a pharmaceutical-grade API and a selective tyrosine kinase inhibitor (TKI). It is clinically used for the treatment of advanced renal cell carcinoma (RCC) by inhibiting vascular endothelial growth factor (VEGF) receptors, thereby suppressing tumor angiogenesis.
Key Details:
Appearance: White to off-white crystalline powder
Solubility: Slightly soluble in water; soluble in methanol, ethanol, and DMSO
Purity (HPLC): ≥99.0%
Assay: 98.0%–102.0% (on dried basis)
Loss on Drying: ≤0.5%
Storage: Store in a cool (2–8°C), dry, light-protected container; shelf life 24–36 months under proper storage.